TECOGEN INC.·4

Mar 23, 2:32 PM ET

Hatsopoulos John 4

4 · TECOGEN INC. · Filed Mar 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Tecogen (TGEN) Director John Hatsopoulos Exercises Options

What Happened

  • John Hatsopoulos, a director of Tecogen, exercised stock options (transaction code M) on March 20, 2026. The filing shows he acquired 50,000 shares at $0.88 per share (total $44,000) and on the same date disposed of 50,000 shares at $0.88 per share (total $44,000).
  • This is an option exercise (derivative transaction), not an open-market purchase or a grant-based award. The simultaneous acquisition and disposition pattern is commonly seen in cashless exercises or sell-to-cover transactions, though the filing itself does not state the reason.

Key Details

  • Transaction date: 2026-03-20; Price per share: $0.88.
  • Acquired: 50,000 shares for $44,000 (exercise of stock options).
  • Disposed: 50,000 shares for $44,000 (reported as a derivative disposition on the same date).
  • Footnotes: F1—Shares acquired pursuant to exercise of Stock Option Agreement dated 9/20/2023; F2—Exercise of Stock Option Agreement dated 9/20/2023.
  • Shares owned after the transaction: not specified in the provided filing details.
  • Filing date: 2026-03-23 — the Form 4 was filed within the standard reporting window (timely).

Context

  • For retail investors: exercises show an insider converting options into shares. When some shares are sold the same day, that often reflects a cashless exercise or sell-to-cover taxes/fees rather than a directional bet on the stock.
  • This report involves a director (not a >10% owner disclosure). The filing is informational; it does not explain the insider’s motivation.

Insider Transaction Report

Form 4
Period: 2026-03-20
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-20$0.88/sh+50,000$44,0001,038,951 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F2]
    2026-03-20$0.88/sh50,000$44,0000 total
    Exercise: $0.88From: 2024-09-20Exp: 2033-09-20Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Shares acquired pursuant to exercise of Stock Option Agreement dated 9/20/2023
  • [F2]Exercise of Stock Option Agreement dated 9/20/2023
Signature
/s/ John N. Hatsopoulos|2026-03-23

Documents

1 file
  • 4
    wk-form4_1774290743.xmlPrimary

    FORM 4